Summary
Figma has 3 registry-verified rows in the CertReports index, last verified 17 Sep 2026. The strongest row is FedRAMP: FedRAMP Authorized. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.
Reviewer brief
As of 17 Sep 2026, Figma is listed in the FedRAMP registry as FedRAMP Authorized, with issuance dated 28 Feb 2025 and an authorization assessment performed by Schellman Compliance, LLC. As of 17 Sep 2026, Figma is listed in the CSA STAR registry at Level 1 self-assessment (CAIQ), issued 13 Apr 2022. As of 17 Sep 2026, Figma is listed in the EU-US Data Privacy Framework registry as Active, covering the UK Extension, EU-US, and SW-US Certifications, issued 16 Nov 2018 and expiring 22 Jul 2027. As of 17 Sep 2026, no public evidence found for SOC 2. As of 17 Sep 2026, no public evidence found for HIPAA.
- FedRAMP: listed in FedRAMP registry as FedRAMP Authorized (issued 28 Feb 2025; assessed by Schellman Compliance, LLC) as of 17 Sep 2026.
- CSA STAR: listed in CSA STAR registry at Level 1 self-assessment (CAIQ), issued 13 Apr 2022, as of 17 Sep 2026.
- EU-US Data Privacy Framework: listed in DPF registry as Active (UK Extension, EU-US, SW-US Certifications), issued 16 Nov 2018, expires 22 Jul 2027, as of 17 Sep 2026.
Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 17 Sep 2026; it is regenerated whenever a row changes.
Among design tools vendors
3verified rows
Category median 1, across 24 indexed design tools vendors. Figma has more verified rows than 100 percent of them.
design-collaborationdesign-systemprototypingui-ux
Compare with similar vendors
Pick your own comparisonCompliance grid
Legal artefacts
No DPA, BAA or subprocessor list has been captured from a public page yet. Registry rows above do not depend on this.
Subprocessors
No subprocessor list captured yet.
Similar vendors with evidence
Related by product tags and the Design tools category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.
